Akiyama, Misaki
Kamei, Koichi http://orcid.org/0000-0003-3528-6961
Nishi, Kentaro
Kaneda, Tomoya
Inoki, Yuta
Osaka, Kei
Sato, Mai
Ogura, Masao
Ito, Shuichi
Article History
Received: 8 May 2023
Accepted: 26 February 2024
First Online: 12 March 2024
Declarations
:
: Koichi Kamei has received research funding from the Public Foundation of Vaccination Research Center, and the Taiju Life Social Welfare Foundation; donations from Chugai Pharmaceutical Co. Ltd., Teijin Pharma Ltd., Kyowa Kirin Co. Ltd., Shionogi & Co. Ltd., Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma Co. Ltd, and Otsuka Pharmaceutical Co. Ltd.; and lecture fees from Terumo Co. Ltd., Baxter Ltd., and Zenyaku Kogyo Co., Ltd. Shuichi Ito has received research funding from Zenyaku Kogyo Co., Ltd., and Teijin Pharma Ltd.; and honoraria from Astrazeneca PLC and Alexion Pharmaceuticals Inc.
: This study was approved by the Ethics Committee of the National Center for Child Health and Development (Approval no. 2022–169).
: Not applicable.
: Not applicable.